About Morepen Laboratories
Morepen Laboratories is a company based in Solan (India) founded in 1984. The company has 3,130 employees as of March 31, 2024. Morepen Laboratories offers products and services including Active Pharmaceutical Ingredients and Home Diagnostics.
- Headquarter Solan, India
- Employees 3130 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Morepen Laboratories Limited
-
Annual Revenue
$211.51 M (USD)7.43as on Mar 31, 2025
-
Net Profit
$13.81 M (USD)22.73as on Mar 31, 2025
-
EBITDA
$19.9 M (USD)12.77as on Mar 31, 2025
-
Latest Funding Round
$59.16 M (USD), Post-IPO
May 21, 2021
- Investors
-
Employee Count
3130
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Morepen Laboratories
Morepen Laboratories is a publicly listed company on the NSE with ticker symbol MOREPENLAB in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Morepen Laboratories
Morepen Laboratories offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients and Home Diagnostics.
Active pharmaceutical ingredients are produced by Morepen for various therapeutic uses in global markets.
Home diagnostics products such as blood glucose and blood pressure monitors are manufactured by Morepen for self-care purposes.
People of Morepen Laboratories
Unlock access to complete
Unlock access to complete
Funding Insights of Morepen Laboratories
Investors in Morepen Laboratories
Morepen Laboratories has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Corinth Group of Switzerland.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for Morepen Laboratories
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Morepen Laboratories
Investment portfolio details for Morepen Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Morepen Laboratories
Detailed financials for Morepen Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Morepen Laboratories Comparisons
Peer comparison for Morepen Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Morepen Laboratories
Detailed competitors of Morepen Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Morepen Laboratories
Complete news archive for Morepen Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Morepen Laboratories
Morepen Laboratories was founded in 1984 and raised its 1st funding round 37 years after it was founded.
Morepen Laboratories is headquartered in Solan, India. It is registered at Solan, Himachal Pradesh, India.
Sanjay Suri is the current CEO of Morepen Laboratories.
As of Mar 31, 2024, the latest employee count at Morepen Laboratories is 3,130.
Annual revenue of Morepen Laboratories is $211.51M as on Mar 31, 2025.
Morepen Laboratories was established in 1984 in Solan, India, within the pharmaceuticals sector. Active pharmaceutical ingredients, formulations, diagnostic tools, and fast-moving health goods are produced and distributed. Over-the-counter healthcare items, nutraceuticals, wellness solutions, and healthy cures form part of the portfolio. Self-care devices, including blood pressure and glucose monitors, are also supplied to support consumer health needs.
Morepen Laboratories offers Active Pharmaceutical Ingredients and Home Diagnostics.
Yes, Morepen Laboratories is publicly traded on NSE under the ticker symbol MOREPENLAB.
Morepen Laboratories has 1 investor. Key investors include Corinth Group of Switzerland.
The ticker symbol of Morepen Laboratories is MOREPENLAB on NSE.